Table 3.
Summary of ITP case(s) presented with CAD and managed conservatively.
| References | Age (year) | Gender | ACS | Baseline PLT (× 109/L) | Intervention | Anticoagulation | ITP treatment | Antiplatelet regimen | Bleeding | Death | MI due to ITP meds |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Argawal et al. (32) | 67 | M | NSTEMI | < 10 | Conservative due to low PLT | None | Steroids, IVIG | None | No | No | Yes, developed the current NSTEMI after 3rd dose IVIG |
| Tabata et al. (33) | 75 | F | NSTEMI (vasospasm) | 5 | Conservative as it was vasospasm | None | None | None | No | No | NA |
NSTEMI: Non ST-Elevation Myocardial Infarction; PLT: Platelet; IVIG: Intravenous Immunoglobulins; ITP: Immune Thrombocytopenia Purpura.